Literature DB >> 1290402

Single-dose toxicokinetics of aluminum in the rat.

M Wilhelm1, X J Zhang, D Hafner, F K Ohnesorge.   

Abstract

The toxicokinetics of aluminum (Al) in male Wistar rats was studied after single intragastric (IG) doses of 1000 and 12,000 micrograms Al/kg and intravenous (IV) doses of 10, 100, 1000, and 12,000 micrograms Al/kg. Serial blood samples, daily samples of urine and feces as well as brain, liver, kidney, spleen, quadriceps muscle, and femur samples were collected. Al was measured by atomic absorption spectrometry. Al blood profiles after IV doses were adequately described by a two-compartment open model. Al toxicokinetics was dose dependent and appeared to plateau at 12,000 micrograms/kg. At IV doses between 10 and 1000 micrograms/kg the terminal half-life of elimination from whole blood (t1/2 beta) increased from 29.9 +/- 7.8 to 209.3 +/- 32.6 min, and the total body clearance (CL) decreased from 2.45 +/- 0.64 to 0.28 +/- 0.03 ml min-1 kg-1. Following an IV bolus of 10 and 100 micrograms/kg the administered Al was recovered completely from urine (94.4% +/- 9.9% and 98.5% +/- 3.2%). Twenty-nine days after the IV dose of 1000 micrograms/kg daily renal excretion decreased to baseline values while only 55.1% +/- 8.0% of the dose was excreted. Nineteen days after the single IV dose of 1000 micrograms/kg Al accumulated in liver (28.1 +/- 7.7 versus 1.7 +/- 0.5 micrograms/g of control rats) and spleen (72.5 +/- 21.1 versus < 0.4 microgram/g). After the single 1000 micrograms/kg IG dose no absorption of Al was detectable. The IG dose of 12,000 micrograms/kg resulted in a maximum blood Al level of 47.9 +/- 12.4 micrograms/l after 50 min.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1290402     DOI: 10.1007/bf01972620

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  20 in total

1.  A central venous catheter for long-term studies on drug effects and pharmacokinetics in Munich minipigs.

Authors:  W Schmidt; A Dehn; J F Hutter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

2.  [Aluminum concentration in the bones and brain following the administration of antacids].

Authors:  H Zumkley; H P Bertram; M Brandt; M Roedig; S Spieker; K Kisters
Journal:  Fortschr Med Suppl       Date:  1987

3.  Influence of storage conditions on aluminum concentrations in serum, dialysis fluid, urine, and tap water.

Authors:  M Wilhelm; F K Ohnesorge
Journal:  J Anal Toxicol       Date:  1990 Jul-Aug       Impact factor: 3.367

4.  Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone.

Authors:  D A Henry; W G Goodman; R K Nudelman; N C DiDomenico; A C Alfrey; E Slatopolsky; T M Stanley; J W Coburn
Journal:  Kidney Int       Date:  1984-02       Impact factor: 10.612

5.  Increased concentration of aluminium in the brain of a parenterally fed preterm infant.

Authors:  N J Bishop; M J Robinson; M Lendon; C D Hewitt; J P Day; M O'Hara
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

6.  Hepatic aluminum accumulation in children on total parenteral nutrition.

Authors:  G L Klein; W E Berquist; M E Ament; J W Coburn; N L Miller; A C Alfrey
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-11       Impact factor: 2.839

7.  Aluminum load in chronic intermittent plasma exchange.

Authors:  M Wilhelm; K B Sprenger; U Vossas; F K Ohnesorge
Journal:  J Toxicol Clin Toxicol       Date:  1987

8.  Kinetics of aluminum in rats I: Dose-dependent elimination from blood after intravenous administration.

Authors:  S M Pai; S Melethil
Journal:  J Pharm Sci       Date:  1989-03       Impact factor: 3.534

9.  Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat.

Authors:  D H Froment; B Buddington; N L Miller; A C Alfrey
Journal:  J Lab Clin Med       Date:  1989-09

10.  Differences in plasma and tissue aluminum concentrations due to different aluminum-containing drugs in patients with renal insufficiency and with normal renal function.

Authors:  B Winterberg; H Bertram; N Rolf; M Roedig; K Kisters; S Remmers; C Spieker; H Zumkley
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1987-12
View more
  2 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Physiology-based toxicokinetic modelling of aluminium in rat and man.

Authors:  Karin Weisser; Wilhelm Huisinga; Christoph Hethey; Niklas Hartung; Gaby Wangorsch
Journal:  Arch Toxicol       Date:  2021-08-14       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.